Independent Newspaper Nigeria on MSN14h
End Stage Kidney DiseaseDr MKO AbimbolaEnd-stage kidney disease is the last stage (5th stage) of chronic kidney disease (CKD). ESRD is also called kidney failure, which develops when the treatment of CKD is either delayed ...
Dr Sanjay Agrawal applies for patent for a specialized formulation for CKD related nutritional deficiencies: Shardul Nautiyal, Mumbai Wednesday, April 2, 2025, 08:00 Hrs [IST] Dr ...
On the occasion of World Kidney Day, Manipal Hospital Millers Road, hosted an awareness session to highlight the growing ...
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...
In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...
Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...
Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...
At the American College of Cardiology 2025 Annual Scientific Session, John W. Ostrominski, MD, of Brigham and Women’s Hospital, dives into the nuanced safety profile of finerenone for high-risk ...
Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...
Chronic kidney disease (CKD), affecting 35.5 million Americans, often goes undiagnosed. High blood pressure and diabetes are key risk factors. Early intervention can prevent progression, yet many ...
Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback